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Background. Oxidative stress induced by reactive oxygen and nitrogen species is critically involved in the impairment of 𝛽-
cell function during the development of diabetes. Methods. HIT-T15 cells were cultured in 5% CO
2
and then preincubated
with Gelam honey extracts (20, 40, 60, and 80𝜇g/mL) as well as quercetin (20, 40, 60, and 80 𝜇M), prior to stimulation
by 20 and 50mM of glucose. Cell lysate was collected to determine the effect of honey extracts and quercetin on the stress
activated NF-𝜅B, MAPK pathways, and the Akt (ser473) activated insulin signaling pathway. Results. HIT-T15 cells cultured under
hyperglycemic conditions demonstrated insulin resistancewith a significant increase in the levels ofMAPK,NF-𝜅B, and IRS-1 serine
phosphorylation (ser307); however, Akt expression and insulin contents are significantly decreased. Pretreatment with quercetin
and Gelam honey extract improved insulin resistance and insulin content by reducing the expression of MAPK, NF-𝜅B, and IRS-1
serine phosphorylation (ser307) and increasing the expression of Akt significantly. Conclusion. Gelam honey-induced differential
expression of MAPK, NF-𝜅B, IRS-1 (ser307), and Akt in HIT-T15 cells shows that Gelam honey exerts protective effects against
diabetes- and hyperglycemia-induced oxidative stress by improving insulin content and insulin resistance.
1. Introduction
Diabetes is a chronic disease that occurs when the pancreas
does not produce enough insulin or when the body cannot
effectively use the insulin it produces [1]. Loss of 𝛽-cell fun-
ction caused by reduced insulin synthesis and secretion is
one of the key events in the pathogenesis of type 2 diabetes.
Normal 𝛽 cells can compensate for insulin resistance by
increasing insulin secretion, but insufficient compensation
leads to the onset of glucose intolerance [2–4].
Chronic hyperglycemia is a cause of impaired insulin
biosynthesis and secretion [5], the progression of which
causes insulin resistance and is often accompanied by 𝛽-cell
degranulation and apoptosis [6]. This process is called “glu-
cose toxicity” andhas been demonstrated in various studies in
vivo [7] and in vitro [8–10]. Oxidative stress induced by reac-
tive oxygen species (ROS) and nitrogen species produced by
several biochemical pathways associated with hyperglycemia
(glucose autooxidation, polyol pathway, prostanoid synthesis,
and protein glycation) is critically involved in the impairment
of 𝛽-cell function during the development of type 2 diabetes
[11]. It has been reported that extracellular hyperglycemia
causes intracellular hyperglycemia in 𝛽-cells leading to the
induction of ROS [5] which becomes exacerbated, through
lack of antioxidant enzymes such as catalase, glutathione
peroxidase, and superoxide mutase in the pancreatic islet of
diabetic animals [12].
ROS can function as signaling molecules to activate a
number of stress sensitive pathways that are linked to insulin
resistance, decreased insulin secretion, and content [13],
ultimately leading to late complications of diabetes [14]. This
transient exposure of 𝛽-cells to oxidative stress interrupts
the normal coupling of glucose metabolism to insulin secre-
tion by activating stress signaling pathways [15]. The most
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extensively studied is the intracellular pathway leading to
the activation of the nuclear factor-𝜅B (NF-𝜅B) [16], which
plays a critical role in mediating immune and inflammatory
responses. Following activation, NF-𝜅B translocates to the
nucleus, resulting in the subsequent transcription of genes
involved in the production of inflammatory cytokines that
promotes the development of insulin resistance [16]. A recent
study on bovine endothelial cells found that exposure to
hyperglycemia initially increased the production of intracel-
lular ROS, followed by activation of NF-𝜅B [17].
In diabetes, oxidative stress also activates the p38mitogen
activated protein kinase (MAPK) pathway which leads to
activation of the serine kinases which promote the degra-
dation of insulin receptor substrate (IRS), thus reducing
the insulin signaling activity which is responsible for the
development of insulin resistance [18]. A streptozotocin-
induced diabetic rat model showed an increase in MAPK
activity as compared to controls, which was mediated by the
production of ROS [18]. Insulin receptors (IR) are cell surface
receptors with 𝛼 and 𝛽 subunits, possessing intrinsic tyrosine
kinase activity. Insulin binds to the IR and induces tyrosine
autophosphorylation of the IR 𝛽 subunit. The activated IR
subsequently phosphorylate their substrates including ins-
ulin receptor substrate (IRS-1). Tyrosine phosphorylated IRS-
1 recruits a number of SH2 containing signal transducers,
which activate several signaling pathways. Serine phosphory-
lated IRS-1 (ser307) inhibits insulin signal transduction in a
variety of cells by steric hindrance of the interaction between
IR and IRS-1. In the presence of insulin activated serine
kinases, phosphorylation of IRS-1 occurs at the serine307 site,
which decreases the IRS-1 tyrosine phosphorylation, thereby
decreasing the activation of insulin signaling pathway which
may result in insulin resistance [19].
Recently, protein kinase B (PKB or Akt) has been shown
to function in the insulin-signaling cascade by phospho-
rylating transcription factors which are responsible for the
transcription and expression of genes related to insulin
synthesis and secretion [20, 21]. Therefore Akt is necessary
for normal pancreatic 𝛽 cell function and insulin secretion.
Previous studies reported that inactivation of Akt can lead to
insulin resistance, decreased𝛽 cellmass, and impaired insulin
secretion [22, 23]. Our previous study also demonstrated
that the following flavonoids quercetin, chrysin, and luteolin
present in the Gelam honey also had antioxidant effect [24].
The protective effect of quercetin was significantly higher
than that of the other flavonoids which is consistent with the
data reported by Lukacˇ´ınova´ et al. [25].
The aim of our present study is to determine the effect
of Gelam honey extract and quercetin on the stress activated
NF-𝜅B and MAPK pathways and IRS-1 serine phosphoryla-
tion causing insulin resistance and the Akt activated insulin
signaling pathway, causing increase in insulin content.
2. Research Design and Methods
2.1. Extraction of Phenolic Compounds from Honey by Solid
Phase Extraction (SPE). Gelam honey samples (Department
ofAgriculture, Parit Botak, Johor,Malaysia) were subjected to
base hydrolysis and extracted with ethyl acetate as described
by Wahdan [26] and Seo and Morr [27]. The recovered
fractions were combined and dried under nitrogen gas.
2.2. Determination of the Phenolic Content. Phenolic com-
pounds from the extract were assayed using Folin-Ciocalteau
assay [28]. Briefly the extract (1mL) was added to 10% Folin-
Ciocalteu reagent (Sigma F9252) and 0.5% sodium carbonate.
The contents were thoroughlymixed and allowed to stand for
2 hours. The absorbance of the blue colour that developed
after 2 hours was read at 765 nm. Results were expressed in
micrograms of gallic acid per gram of the extract, using a
standard curve generated with gallic acid (Sigma G7384).
2.3. Determination of the Flavonoid Content. The total
flavonoid (TF) content was determined spectrophotometri-
cally [29]. Briefly 1mL of honey extract or a standard solution
of quercetin (Sigma Q4951) (10, 50, 100, 150, 200, 250𝜇g/mL)
in distilled water was added to a 10mL volumetric flask
containing 4mL of double distilled water, 300 𝜇L of NaNo
2
(5%, v/v), and 300 𝜇L of 10% AlCl
3.
The solution was allowed
to stand at room temperature in the dark for 30 minutes
and the absorbance was read at 430 nm. The TF content was
determined using the standard curve of quercetin (𝜇g/mL).
TF content was expressed as 𝜇g of quercetin equivalents in
1 g of extract.
2.4. Cell Culture. HIT-T15 cells were cultured according to
the instructions provided by ATCC (CRL-1777). The cells
were cultured immediately in T-25 cm flask in the F12 K
medium (ATCC 30-2004) supplemented with 10% FBS and
1% penicillin and streptomycin at 37∘C (5% CO
2
in air). Cells
(3rd passage) were trypsinized and subcultured after 5 days
incubation, with 80% confluency.
2.5. Treatment of HIT-T15 Cells with Quercetin and Gelam
Honey Extract. HIT-T15 cells (5 × 105) were pretreated with
Gelam honey extract (20, 40, 60, 80 𝜇g/mL) and quercetin
(20, 40, 60, 80 𝜇M) for 24 hours; medium was then replaced
with fresh medium. Glucose (Sigma G8769) (20 or 50mM)
was added and the cells were incubated for another 24 hours.
To investigate inhibitory effects on Akt signaling pathway,
cells were incubatedwith 5𝜇MAkt inhibitorVIII (SantaCruz
Biotechnology sc-203173) for one hour before pretreatment
with quercetin and honey extract. Glucose (20 or 50mM)was
added and followed by incubation for another 24 hours.
2.6. Cell Lysate Preparation. After treatment the cells were
washed twice in PBS and lysed in mammalian cell lysis buffer
(SigmaMCL-1) supplementedwith protease and phosphatase
inhibitors. Insoluble materials were eliminated by centrifu-
gation (12,000×g, 10min, 4∘C), and protein concentration in
the supernatant was determined by Bradford assay (Bio-Rad
Laboratories).
2.7. Measurement of Insulin Content. Insulin content was
determined by pretreating 5 × 105 HIT-T15 cells with Gelam
honey extract (20, 40, 60, 80 𝜇g/mL) and quercetin (20,
40, 60, 80 𝜇M) for 24 hours following which the medium
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was replaced with fresh medium. Then glucose of either
20mM or 50mM was added and the cells were incubated
for another 24 hours. At the end of this incubation, the cells
were centrifuged and the supernatant was removed. The cell
pellet was resuspended in PBS and sonicated. The cell lysate
was used to estimate the quantity of insulin by ELISA (Crystal
Chem Inc, USA). Insulin content was normalized to the total
protein concentration [29].
2.8. Western Blot Analysis. Thirty microgram of protein
extracts were loaded on 10% SDS-polyacrylamide gel and
transferred to activated nitrocellulose membrane. The mem-
brane was blocked with tris-buffered saline (TBS) containing
5% nonfat milk, and incubated with phosphor-Akt (Ser473),
phosphor-IRS-1 (Ser307), phospho-p65 NFKB (Ser536), and
phospho-p38 MAPK (Thr180/Tyr182) primary antibodies
(obtained from Santa Cruz Laboratories) overnight at 4∘C. 𝛽-
actin was used as a loading control. After extensive washes in
TBS, membranes were incubated for 1 h at room temperature
with the appropriate horseradish peroxidase-conjugated sec-
ondary antibodies and were visualized using chemilumines-
cence substrate according to the manufacturer’s instructions
(Amersham Life Sciences, Little Chalfont, UK). Quantitative
analysis of the protein was performed by Gel Documentation
System (Biospectrum 410, UVP) [30, 31].
2.9. Statistical Analyses. Data were analyzed with one-way
ANOVA using SPSS version 16.0 software. The results were
expressed as the mean ± standard deviation. ∗𝑃 value < 0.05
was considered to be statistically significant.
3. Results
3.1. Total Phenolic and Flavonoid Content. 10 g of liquefied
fresh Malaysian Gelam honey (Apis mellifera) was extracted
using ethyl acetate and the extract was found to contain 52 𝜇g
of gallic acid per gram of extract of total phenolic content
and 6.92 𝜇g of quercetin per gram of extract of total flavonoid
content.
3.2. Effect of Pretreatment with Quercetin and Gelam Honey
Extract on Phospho-p38 MAPK Expression under Normal
andHyperglycemic Conditions. HIT-T15 cells were pretreated
with the quercetin at concentrations of 20, 40, 60, 80 𝜇M
and Gelam honey extract at concentrations of 20, 40, 60,
80 𝜇g/mL for 24 hours, following which they were cultured
with 20mM (Figures 1(a), 1(c), 1(e)) or 50mM (Figures
1(b), 1(d), 1(f)) glucose to determine the phosphorylation
of MAPK. The data revealed that exposure of HIT-T15 cells
to 20 and 50mM glucose significantly increased the level
of phospho-p38 MAPK expression compared to control.
Pretreatment with quercetin and Gelam honey extract sig-
nificantly (𝑃 < 0.05) reduced the ROS-induced expression
of phospho-p38 under 20mM glucose (Figures 1(a), 1(c),
1(e)) by 56% and 40% in a dose-dependent manner. While
pretreatment with quercetin and Gelam honey extract
reduced the expression of phospho-p38 significantly (𝑃 <
0.05) by 69% and 44%, respectively, compared to the cells
that were cultured with 50mM glucose (Figures 1(b), 1(d),
1(f)) alone. The p38 MAPK protein levels from each sample
were normalized to their respective 𝛽-actin protein amounts
(∗𝑃 < 0.05; #𝑃 < 0.005 versus glucose-treated group).
3.3. Effect of Pretreatment with Quercetin and Gelam Honey
Extract on Phospho-p65 NF-𝜅B Expression under Normal
andHyperglycemic Conditions. HIT-T15 cells were pretreated
with the quercetin at concentrations of 20, 40, 60, 80𝜇M
and Gelam honey extract at concentrations of 20, 40, 60,
80 𝜇g/mL for 24 hours, following which they were cultured
with 20mM (Figures 2(a), 2(c), 2(e)) or 50mM (Figures 2(b),
2(d), 2(f)) glucose to determine the phosphorylation of NF-
𝜅B. The phosphorylation of NF-𝜅B was increased in HIT-
T15 cells treated with 20mM and 50mM glucose alone as
compared with control. Pretreatment with the quercetin and
Gelam honey extract showed a 50% and 56% decrease (𝑃 <
0.05) in the expression of phosphorylated NF-𝜅B in a dose
dependent manner in the cells that were cultured in 20mM
(Figures 2(a), 2(c), 2(e)) glucose. Pretreatment with quercetin
andGelamhoney extract significantly (𝑃 < 0.05) decrease the
expression of phosphorylated NF-𝜅B under 50mM glucose
(Figures 2(b), 2(d), 2(f)) by 36% and 61% in a dose dependent
manner.The phosphorylated NF-𝜅B protein levels from each
sample were normalized to their respective 𝛽-actin protein
amounts (∗𝑃 < 0.05; #𝑃 < 0.005 versus glucose-treated
group).
3.4. Effect of Pretreatment with Quercetin and Gelam Honey
Extract on pIRS-1 (ser307) Expression under Normal and
Hyperglycemic Conditions. HIT-T15 cells were pretreated
with the quercetin at concentrations of 20, 40, 60, 80𝜇M
and Gelam honey extract at concentrations of 20, 40, 60,
80 𝜇g/mL for 24 hours, following which they were then cul-
turedwith 20mM (Figures 3(a), 3(c), 3(e)) or 50mM (Figures
3(b), 3(d), 3(f)) glucose to determine the phosphorylation of
IRS-1 (ser307). The phosphorylation of IRS-1 (ser307) was
increased in HIT-T15 cells treated with 20mM and 50mM
glucose alone as compared with control. Pretreatment with
the quercetin and Gelam honey extract showed a 46% and
52% decrease (𝑃 < 0.05) in the expression of pIRS-1 (ser307)
in a dose-dependent manner in the cells that were cultured
in 20mMglucose (Figures 3(a), 3(c), 3(e)). Pretreatment with
quercetin and Gelam honey extract significantly (𝑃 < 0.05)
decreased the expression of pIRS-1 (ser307) under 50mM
glucose (Figure 3(b), 3(d), 3(f)) by 40% and 50% in a dose
dependent manner. The pIRS-1 protein levels from each
sample were normalized to their respective 𝛽-actin protein
amounts ( ∗𝑃 < 0.05; #𝑃 < 0.005 versus glucose-treated
group).
3.5. Effect of Pretreatment with Quercetin and Gelam Honey
Extract on pAkt (ser473) Expression under Normal andHyper-
glycemic Conditions. HIT-T15 cells were pretreated with the
quercetin at concentrations of 20, 40, 60, 80𝜇M and Gelam
honey extract at concentrations of 20, 40, 60, 80 𝜇g/mL for
24 hours, following which they were then cultured with 20
or 50mM glucose to determine the phosphorylation of Akt
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Figure 1: Effect of quercetin and Gelam honey extract on phosphor-p38 MAPK expression. Quantitative analysis and representative western
blot analysis of phospho p38MAPK in HIT-T15 cells pretreated with quercetin and honey extract in cells cultured in 20mM ((a), (c), (e)) and
50mM ((b), (d), (f)) glucose. The results were normalized with 𝛽-actin antibody. Data were presented as the mean ± standard deviation. (e)
∗𝑃 < 0.05; #𝑃 < 0.005 quercetin and honey extract treated compared to the 20mM glucose alone. (f) ∗𝑃 < 0.05; #𝑃 < 0.005 quercetin and
honey extract treated compared to the 50mM glucose alone.
(ser473). Akt (ser473) phosphorylation in HIT-T15 cells was
markedly reduced following 20mM (Figures 4(a), 4(c), 4(e))
and 50mM (Figures 4(b), 4(d), 4(f)) glucose treatment, but
the trend was reversed after pretreatment with quercetin and
Gelam honey extract. Pretreatment of the cells with different
concentration of quercetin and honey extract for 24 hours
significantly increase the expression of pAkt (ser473) up to
32% and 70% respectively, compared to the cells that were
cultured alone with 20mM glucose (Figure 4(a), 4(c), 4(e)).
On the other hand, pretreatment with quercetin and honey
extract increases the expression of pAkt (ser473) significantly
(𝑃 < 0.05) up to 19% and 54%, respectively, compared to the
cells that were cultured alone with 50mM glucose (Figures
4(b), 4(d), 4(f)). The cells that were exposed to Akt inhibitor
VIII prevented the quercetin and honey extract-induced Akt
ser473 phosphorylation. The pAkt protein levels from each
sample were normalized to their respective 𝛽-actin protein
amounts (∗𝑃 < 0.05; #𝑃 < 0.005 versus glucose-treated
group).
3.6. The Effect of Quercetin and Gelam Honey Extract and Akt
Inhibitor on Insulin Content of the Cells. To determine the
effect of ROS on insulin content, the cells were pretreated
with Gelam honey extract (20, 40, 60, 80 𝜇g/mL) and the
quercetin (20, 40, 60, 80 𝜇M) before treating the HIT-T15
cells with 20mM and 50mM glucose and the insulin content
was measured. As shown in Figure 5(a), pretreatment with
quercetin andGelamhoney extract increased the insulin con-
tent significantly (𝑃 < 0.05) up to 64% and 78%, respectively,
compared to the cells that were cultured alone with 20mM
glucose. Figure 5(b) shows that pretreatment with quercetin
and Gelam honey extract increased the insulin content
significantly (𝑃 < 0.05) up to 34% and 48% respectively,
compared to the cells that were cultured alone with 50mM
glucose. Exposure of cells to Akt inhibitor VIII for 1 hour
before pretreatment with quercetin (20, 80 𝜇M) and Gelam
honey extract (20, 80 𝜇g/mL) decreases the insulin content
significantly (𝑃 < 0.05) up to 12% and 6% respectively,
compared to the cells that were pretreated with quercetin
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Figure 2: Effect of quercetin and Gelam honey extract on phosphor-p65 NF-𝜅B expression. Quantitative analysis and representative western
blot analysis of phospho p65 NF-𝜅B in HIT-T15 cells pretreated with quercetin and honey extract in cells cultured in 20mM ((a), (c), (e)) and
50mM ((b), (d), (f)) glucose. The results were normalized with 𝛽-actin antibody. Data were presented as the mean ± standard deviation. (e)
∗𝑃 < 0.05; #𝑃 < 0.005 quercetin and honey extract treated compared to the 20mM glucose alone. (f) ∗𝑃 < 0.05; #𝑃 < 0.005 quercetin and
honey extract treated compared to the 50mM glucose alone.
and honey extract cultured in 20mM glucose (Figure 5(a))
without Akt inhibitor. The cells that were exposed to Akt
inhibitor VIII for 1 hour and pretreated with quercetin (20,
80𝜇M) and Gelam honey extract (20, 80 𝜇g/mL) decrease
the insulin content significantly (𝑃 < 0.05) up to 10% and
8% respectively, compared to the cells that were pretreated
with quercetin and honey extract before culturing in 50mM
glucose (Figure 5(b)) without Akt inhibitor.
4. Discussions
In our previous study, we investigated the antioxidant effect
of the Malaysian Gelam honey and some of its flavonoid
components (chrysin, luteolin, and quercetin) individu-
ally on pancreatic hamster cells (HIT-T15) cultured under
hyperglycemic conditions. Our data demonstrated that the
cultured cells, pretreated with the extract of the Gelam
honey and the different flavonoid components (quercetin,
luteolin, and chrysin) at varying concentrations for 24 hours,
protected the 𝛽 cell from oxidative damage caused by ROS
induced by hyperglycemia [24]. Therefore in our present
study, we determined the effect of Gelam honey extract and
quercetin on the stress-activated NF-𝜅B, MAPK pathways
and IRS-1 serine phosphorylation causing insulin resistance
and the Akt-activated insulin signaling pathway, causing
increase in insulin content.
Several studies have demonstrated that flavonoids may
reduce hyperglycemia and exert protective effects against
nonenzymatic glycation of proteins in animals [32, 33]. Two
important studies in streptozotocin-(STZ-) induced diabetes
mellitus [33] and alloxan-induced diabetes mellitus in rats
[25] have demonstrated that quercetin may even reverse
the hyperglycemia close to the normal levels. More recently
hyperglycemia has been implicated in the stress-activated
signaling pathways such as p-65 NF-𝜅B and p-38 MAPK
[17]. Activation of these pathways is linked not only to the
development of the late complications of diabetes, but also to
insulin resistance and 𝛽-cell dysfunction [16].
Another study on bovine endothelial cells has revealed
that exposure to hyperglycemia initially increased the
6 International Journal of Endocrinology
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Figure 3: Effect of quercetin on pIRS-1 (ser307) expression. Quantitative analysis and representative western blot analysis of pIRS-1 (ser307)
in HIT-T15 cells pretreated with quercetin and Gelam honey extract in cells cultured in 20mM ((a), (c), (e)) and 50mM ((b), (d), (f)) glucose.
The results were normalizedwith𝛽 actin antibody. Datawere presented as themean± standard deviation. (e) ∗𝑃 < 0.05; #𝑃 < 0.005 quercetin
and honey extract treated compared to the 20mM glucose alone. (f) ∗𝑃 < 0.05; #𝑃 < 0.005 quercetin and honey extract treated compared
to the 50mM glucose alone.
production of intracellular ROS, followed by activation of
p-65 NF-𝜅B, subsequently increasing the PKC activity, the
advanced glycation end products (AGE), and sorbitol levels.
It has been shown that when hyperglycemia-induced ROS
production was reduced, the hyperglycemia-induced effects
on NF-𝜅B, PKC, AGE, and sorbitol were also suppressed [34,
35]. In addition, 𝛼-phenyl-tert-butylnitrone, a spin-trapping
agent that reacts with ROS, significantly reduces the sever-
ity of hyperglycemia in both alloxan- and streptozotocin-
induced diabetes and inhibits the activation of p-65 NF-𝜅B
[36]. It has been shown that both the activation of p-65NF-𝜅B
and the increase in oxidative stress are reduced in rats fed on a
diet supplementedwithmultiple antioxidants [37].These data
indicate that activation of p-65 NF-𝜅B is an initial signaling
event caused by ROS that leads to cellular dysfunction and
damage [36]. Our findings suggest that in pancreatic hamster
cell, quercetin and Gelam honey extracts are able to reduce
p-38 MAPK and p-65 NF-𝜅B activation, by its antioxidant
effect on ROS.This gives further support that oxidative stress
is the initial change induced by high glucose. Our data shows
that exposure of HIT-T15 cells to 20 and 50mM glucose
caused a significant increase level of phospho-p38 MAPK
(Figure 1) expression and phospho-p65 NF-𝜅B (Figure 2)
expression compared to control. Pretreatment with quercetin
andGelam honey extract significantly (𝑃 < 0.05) reduced the
ROS-induced expression of phospho-p38 MAPK (Figure 1)
and phospho-p65 NF-𝜅B (Figure 2) under 20 and 50mM
glucose.
Activation of p38 MAPK has been suggested as one of
the potential candidates for mediating IRS-1 serine phospho-
rylation (ser307) by cellular stresses [38–40] causing steric
hindrance of the interaction between IR and IRS-1. Our data
shows that phosphorylation of IRS-1 (ser307) was increased
in HIT-T15 cells treated with 20 and 50mM glucose alone as
compared with control. Pretreatment with the quercetin and
Gelam honey extract significantly decreased (𝑃 < 0.05) the
expression of pIRS-1 (ser307) (Figure 3) in a dose-dependent
manner in the cells that were cultured in 20 and 50mM
International Journal of Endocrinology 7
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Figure 4: Effect of quercetin and Gelam honey extract on pAkt (Ser473) expression.Quantitative analysis and representative western blot
analysis of pAkt (Ser473) in HIT-T15 cells pretreated with quercetin and honey extract in cells cultured in 20mM ((a), (c), (e)) and 50mM
((b), (d), (f)) glucose. A sustained increase in the level of pAkt (ser473) was observed after pretreatment with quercetin and honey extract. Akt
inhibitor VIII prevented the expression Akt ser473 phosphorylation induced by quercetin and honey extract. The results were normalized
with 𝛽 actin antibody. Data were presented as the mean ± standard deviation. (e) ∗𝑃 < 0.05; #𝑃 < 0.005 quercetin and honey extract treated
compared to the 20mM glucose alone. (f) ∗𝑃 < 0.05; #𝑃 < 0.005 quercetin and honey extract treated compared to the 50mM glucose alone.
glucose (Figure 3). There is possibility that ROS generation,
in response to stress stimuli, may promote IRS-1 (ser307)
phosphorylation.
Cho et al. in 2001 reported that mice lacking the p-Akt
(ser473) protein are insulin resistant, with impaired insulin
secretion [41]. Ernesto et al. reported that Akt (ser473) is nec-
essary for normal pancreatic 𝛽-cell function and described a
novel regulatory role for Akt signaling in insulin secretion
[42]. Several studies reported that a decrease in insulin
secretion and insulin resistance induced by hyperglycemia
has been associated with decreased Akt activity [19, 20, 41,
43, 44]. Our data validates the above statement by showing
that Akt (ser 473) (Figure 4) phosphorylation in HIT-T15
cells was markedly reduced following 20 and 50mM glucose
treatment but was reversed after pretreatment with quercetin
and Gelam honey extract. Our data suggest that Akt (ser473)
(Figure 4) phosphorylation and insulin content (Figure 5)
were increased after pre-treatment with quercetin and honey
showing the protective effects against 𝛽 cell dysfunction.
The present data shows that treatment with an Akt inhibitor
decreased the insulin content significantly (Figure 5) sup-
porting the previous data reported by Cordero et al. [45] that
Cocoa flavonoids improve insulin signaling and modulate
glucose production via Akt in HepG2 cells.
Growing evidence indicates that ROS are involved in
maintaining normal 𝛽-cell glucose responsiveness. ROS may
have different actions depending on whether the cellular
concentrations are either below or above a specific threshold,
that is, signaling versus toxic effects. H
2
O
2
derived from
glucosemetabolism is one of themetabolic signals for insulin
secretion. Also it has been shown that mitochondrial reactive
oxygen species are obligatory signals for glucose-induced
insulin secretion. ROS produced under short-term exposure,
or under nonhyperglycemic conditions may play a role in
physiological regulation of glucose induced insulin secretion,
while long-term exposure to high glucose induces oxidative
stress in 𝛽 cells [24]. Our data validate the above statement by
showing that cells grown under 20mM glucose (Figure 5(a))
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Figure 5: The effect of flavonoids and Gelam honey extract on insulin content. (a) Effect of pretreatment with quercetin and Gelam honey
extract and the addition of Akt inhibitor VIII on the insulin content in cells cultured in 20mM glucose. There was a significant increase in
insulin content ( ∗𝑃 < 0.05) when the cells were pretreated with quercetin and honey. There was a significant decrease in insulin content
( ∗𝑃 < 0.05) when the cells were treated with Akt inhibitor VIII, before pretreating with quercetin and Gelam honey extract. (b) Effect of
pretreatment with quercetin andGelamhoney and the addition of Akt inhibitor VIII on the insulin content in cells cultured in 50mMglucose.
There was a significant increase in insulin content ( ∗𝑃 < 0.05, #𝑃 < 0.005) when the cells were pretreated with quercetin and honey. There
was a significant decrease in insulin content ( ∗𝑃 < 0.05, #𝑃 < 0.005) when the cells were treated with Akt inhibitor VIII, before pretreating
with quercetin and Gelam honey extract.
under nonhyperglycemic conditions showed an increase in
insulin content compared to the controls, while in cells
grown under 50mMglucose (Figure 5(b)) concentration, the
insulin content was reduced significantly as compared to
controls.
In conclusion, our data suggest the potential use of the
extract fromGelamhoney in treating diabetes, bymodulating
the oxidative stress-induced insulin signalling pathways. The
data provide further support for the implication of oxidative
stress, in 𝛽-cell dysfunction. Further studies are required
to accurately define the mechanisms involved in diabetic
complications at the molecular and biochemical levels.
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